Casdin Partners GP, LLC's Form 4 filing
Standard Biotools Inc. (LAB) · filed Sep 5, 2025
- Accession no.
- 0000919574-25-005603
- Filed
- Sep 5, 2025, 7:08 PM ET
- Trade date
- Sep 3-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $635.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin Partners GP, LLCCIK 0001534260 | Director, 10% Owner |
| Casdin Capital, LLCCIK 0001534261 | Director, 10% Owner |
| Casdin EliCIK 0001534264 | Director, 10% Owner |
| Casdin Partners Master Fund, L.P.CIK 0001534265 | Director, 10% Owner |
| Casdin Private Growth Equity Fund, L.P.CIK 0001823061 | Director |
| Casdin Private Growth Equity Fund GP, LLCCIK 0001864554 | Director |
| Casdin Private Growth Equity Fund II, L.P.CIK 0001891102 | Director |
| Casdin Private Growth Equity Fund II GP, LLCCIK 0001919480 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +250,000 | $1.27 | +$316,400 | 60,525,000 | Indirect | |
| Sep 4, 2025 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +250,000 | $1.28 | +$319,350 | 60,775,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.